Vertex, fresh off an R&D miss, flashes data suggesting their sickle cell CRISPR therapy is working
In one of the strongest bits of evidence yet for the effect CRISPR gene editing can have in people with genetic diseases, Vertex and CRISPR …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
